NCT04694001View on ClinicalTrials.gov

Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

March 28, 2022

Study Completion Date

March 28, 2022

Conditions
StrokeStroke, AcuteStroke, SubacuteChronic Stroke
Interventions
DEVICE

Use of the Atalante exoskeleton

A session includes stand-up, walks, exercises with or without the assistance of the exoskeleton, rotation, side and back step, squat and sitting.

Trial Locations (6)

1200

Cliniques universitaires Saint-Luc, Brussels

2674

Rehazenter, Luxembourg

20119

Hôpital La Musse, La Renaissance Sanitaire, Saint-Sébastien-de-Morsent

56270

Centre mutualiste de Rééducation et de Réadaptation de Kerpape, Ploemeur

62600

Centre Jacques Calvé - Fondation Hopale, Berck

63330

Centre de Médecine Physique et de Réadaptation, Pionsat

All Listed Sponsors
lead

Wandercraft

INDUSTRY